In humans, plasma levels of GM-CSF are endogenously upregulated after stroke and were positively correlated with stroke severity score [48], which may indicate that the increase in this neuroprotective chemokine may be a compensatory mechanism. This evidence concerns the gene CSF2 and stroke disorder.